The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers

被引:232
作者
Kessler, RC
Adler, L
Ames, M
Barkley, RA
Birnbaum, H
Greenberg, P
Johnston, JA
Spencer, T
Üstün, TB
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[2] NYU, Sch Med, Dept Psychiat, New York, NY USA
[3] NYU, Sch Med, Dept Neurol, New York, NY USA
[4] New York Harbor Vet Adm Med Ctr, Psychiat Serv, New York, NY USA
[5] Univ Massachusetts, Sch Med, Boston, MA 02125 USA
[6] Eli Lilly & Co, US Hlth Outcomes, Indianapolis, IN 46285 USA
[7] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[8] WHO, Geneva, Switzerland
关键词
D O I
10.1097/01.jom.0000166863.33541.39
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. The prevalence and workplace consequences of adult attention deficit/hyperactivity, disorder (ADHD) are unknown. Methods: Air ADHD screen was included in a national household survey (n = 3198, ages 18-44). Clinical reinterviews calibrated the screen to diagnoses of Diagnostic and Statistical Manual of Mental Disorders, 4th edition ADHD Diagnoses among workers were compared with responses to the WHO Health and Work performance Questionnaire (HPQ). Results: A total of 4.2% of workers had ADHD. ADHD was associated with 35.0 days of annual lost work performance, with higher associations among blue collar (55.8 days) than professional (12.2 days), technical (19.8 days), or service (32.6 days) workers. These associations represent 120 million days of annual lost work in the U.S. labor force, equivalent to $19.5 billion lost human capital. Conclusions: ADHD is a common and costly workplace condition. Effectiveness trials are needed to estimate the region of interest of workplace ADHD screening and treatment programs.
引用
收藏
页码:565 / 572
页数:8
相关论文
共 47 条
[31]  
ROBINS L, 1995, DIAGNOSTIC INTERVIEW, V4
[32]  
Rubin DonaldB., 1987, MULTIPLE IMPUTATIONS
[33]  
Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541
[34]   Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: Normalization of behavior but not related brain activity [J].
Schweitzer, JB ;
Lee, DO ;
Hanford, RB ;
Zink, CF ;
Ely, TD ;
Tagamets, MA ;
Hoffman, JM ;
Grafton, ST ;
Kilts, CD .
BIOLOGICAL PSYCHIATRY, 2004, 56 (08) :597-606
[35]   Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder [J].
Simpson, D ;
Plosker, GL .
CNS DRUGS, 2004, 18 (06) :397-401
[36]   Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder [J].
Spencer, T ;
Biederman, J ;
Wilens, T ;
Faraone, S ;
Prince, J ;
Gerard, K ;
Doyle, R ;
Parekh, A ;
Kagan, J ;
Bearman, SK .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) :775-782
[37]  
Swensen A., 2004, Journal of Adolescent Health, V35, P346, DOI 10.1016/S1054-139X(04)00055-2
[38]   Attention-deficit/hyperactivity disorder: Increased costs for patients and their families [J].
Swensen, AR ;
Birnbaum, HG ;
Secnik, K ;
Marynchenko, M ;
Greenberg, P ;
Claxton, A .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (12) :1415-1423
[39]   Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder [J].
Turner, DC ;
Clark, L ;
Dowson, J ;
Robbins, TW ;
Sahakian, BJ .
BIOLOGICAL PSYCHIATRY, 2004, 55 (10) :1031-1040
[40]   Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys [J].
Wang, PS ;
Beck, A ;
Berglund, P ;
Leutzinger, JA ;
Pronk, N ;
Richling, D ;
Schenk, TW ;
Simon, G ;
Stang, P ;
Ustun, TB ;
Kessler, RC .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2003, 45 (12) :1303-1311